These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5826304)

  • 1. Relationship of quality control to good manufacturing procedures for lyophilized parenteral products.
    Wickes G
    Bull Parenter Drug Assoc; 1965; 19(5):135-41. PubMed ID: 5826304
    [No Abstract]   [Full Text] [Related]  

  • 2. Good manufacturing practices and clinical supplies.
    Levchuk JW
    J Parenter Sci Technol; 1991; 45(3):152-5. PubMed ID: 1886044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical development, quality control, stability and compatibility of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum antineoplastic agent AP5346.
    Van der Schoot SC; Nuijen B; Sood P; Thurmond KB; Stewart DR; Rice JR; Beijnen JH
    Pharmazie; 2006 Oct; 61(10):835-44. PubMed ID: 17069422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential elements of quality control.
    Boylan JC
    Am J Hosp Pharm; 1983 Nov; 40(11):1936-9. PubMed ID: 6650523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Product improvement through advanced freeze drying techniques.
    Beisswenger HL
    Bull Parenter Drug Assoc; 1969; 23(2):90-100. PubMed ID: 5776424
    [No Abstract]   [Full Text] [Related]  

  • 6. A Regulatory Perspective on Manufacturing Processes Pertaining to Lyophilized Injectable Products.
    Rhieu SY; Anderson DD; Janoria K
    AAPS J; 2020 Aug; 22(5):100. PubMed ID: 32743675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of products prepared by freeze-drying solutions containing organic solvents.
    Seager H; Taskis CB; Syrop M; Lee TJ
    J Parenter Sci Technol; 1985; 39(4):161-79. PubMed ID: 4032158
    [No Abstract]   [Full Text] [Related]  

  • 8. Low temperature vacuum drying of sterile parenterals from ethanol.
    Flamberg DW; Francis DL; Morgan SL; Wickes GF
    Bull Parenter Drug Assoc; 1970; 24(5):209-17. PubMed ID: 5471331
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preparation and stability of suppositories containing lyophilized aminopyrine ascorbate].
    Zoni G; Lazzeretti V
    Boll Chim Farm; 1968 Jul; 107(7):422-30. PubMed ID: 5713459
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of various requirements of the quality assurance procedures for (18)F-FDG injection.
    Hung JC
    J Nucl Med; 2002 Nov; 43(11):1495-506. PubMed ID: 12411554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and substantiation of 25 kGy as sterilization dose for lyophilized human amnion membrane.
    Djefal A; Tahtat D; Khodja AN; Bouzid SS; Remane N
    Cell Tissue Bank; 2007; 8(1):9-12. PubMed ID: 16821108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
    Bozdag S; Dillen K; Vandervoort J; Ludwig A
    J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases.
    Lu B; Xiong SB; Yang H; Yin XD; Chao RB
    Eur J Pharm Sci; 2006 May; 28(1-2):86-95. PubMed ID: 16472996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of parenteral and sterile ophthalmic suspensions--the R & D approach.
    Portnoff JB; Cohen EM; Henley MW
    Bull Parenter Drug Assoc; 1977; 31(3):136-43. PubMed ID: 880416
    [No Abstract]   [Full Text] [Related]  

  • 15. The physical characteristics of lyophilized tablets containing a model drug in different chemical forms and concentrations.
    Sznitowska M; Płaczek M; Klunder M
    Acta Pol Pharm; 2005; 62(1):25-9. PubMed ID: 16022490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
    Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
    Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay automation in control of parenteral products.
    Kavanagh F
    Bull Parenter Drug Assoc; 1970; 24(5):244-9. PubMed ID: 5471334
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance of sterility in freeze-drying of drugs.
    Gallelli JF
    Am J Hosp Pharm; 1968 Dec; 25(12):671-81. PubMed ID: 5723286
    [No Abstract]   [Full Text] [Related]  

  • 19. Cosolvent solubilization and formulation of an aqueous injection of ketoprofen.
    Singhai AK; Jain S; Jain NK
    Pharmazie; 1996 Oct; 51(10):737-40. PubMed ID: 8941941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stability of lyophilized injections of oxytetracycline].
    Hrdý O; Pospísilová B
    Cesk Farm; 1977 Oct; 26(8):359-61. PubMed ID: 608193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.